HKU Scholars Hub: Browsing DSpace

Browsing by Author Leung, N

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 20 of 39 next >

Title	Author(s)	Issue Date	Views
A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B Journal:Gastroenterology	Lai, CL Leung, N Teo, EK Tong, M Wong, F Hann, HW Han, S Poynard, T Myers, M Chao, G Lloyd, D Brown, NA	2005	216
2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B Journal:Gastroenterology	Liaw, Y Gane, E Leung, N Zeuzem, S Wang, Y Lai, CL Heathcote, EJ Manns, M Bzowej, N Niu, J Han, S Hwang, SG Cakaloglu, Y Tong, MJ Papatheodoridis, G Chen, Y Brown, NA Albanis, E Galil, K Naoumov, NV	2009
48 Weeks pegylated interferon alfa-2a is superior to 24 weeks of pegylated interferon alfa-2b in achievingHBeAg seroconversion in chronic hepatitis B infection Proceeding/Conference:Journal of Gastroenterology and Hepatology	Lai, LSW Fung, TT Lai, ST Yiu, J Lam, P Zhang, H Wong, WM Lo, CM Fan, ST Hui, CK Leung, N Lau, G	2006	179
48 Weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection Journal:Alimentary Pharmacology and Therapeutics	Hui, CK Lai, LSW Lam, P Zhang, HY Fung, TT Lai, ST Wong, WM Lo, CM Fan, ST Leung, N Lau, GKK	2006	220
5-year Follow-up of 998 Chronic Hepatitis B Patients to Determine Long-term Safety of Lamivudine and clinical Consequences of Lamivudine-Resistant Mutations Proceeding/Conference:Hepatology	Lok, AS Lai, CL Leung, N Yao, GB Cui, ZY Schiff, ER Dienstag, JL Heathcote, J Little, NR Griffiths, DA Gardner, SD Castiglia, M	2003
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update Journal:Liver International	Liaw, YF Leung, N Guan, R Lau, GKK Merican, I McCaughan, G Gane, E Kao, JH Omata, M	2005	75
Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications Journal:Journal of Clinical Gastroenterology	Hui, CK Leung, N Shek, WH Zhang, HY Luk, JM Poon, RTP Lo, CM Fan, ST Lau, GKK	2008	82
Comparison of real-time PCR assays for monitoring serum HBV DNA levels during antiviral therapy Proceeding/Conference:Journal of Gastroenterology and Hepatology	Zhang, HY Hui, CK Wong, A Lee, NP Leung, N Luk, JM Lau, GKK	2006	181
Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy Journal:Journal of Clinical Microbiology	Hui, CK Bowden, S Zhang, HY Wong, A Lewin, S Rousseau, F MommejaMarin, H Lee, NP Luk, JM Locarnini, S Leung, N Naoumov, NV Lau, GKK	2006
Developing a context-based PBL model Book:Research and Development in Problem-based Learning: Integrity, Innovation, Integration	Tang, C Lai, P Tang, W Davies, H Frankland, S Oldfield, K Walters, M Leung, N Tse, P Taylor, G Tiwari, AFY Yim, M Yuen, E	1997	146
Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir Journal:Hepatology	Leung, N Peng, CY Hann, HW Sollano, J LaoTan, J Hsu, CW Lesmana, L Yuen, MF Jeffers, L Sherman, M Min, A Mencarini, K Diva, U Cross, A Wilber, R LopezTalavera, J	2009	176
Entecavir (ETV) Results in Higher HBV-DNA Reduction vs Adefovir (ADV) In Chronically Infected HBeAg(+) Antiviral-Naive Adults: 48-Week Results (E.A.R.L.Y. STUDY) Proceeding/Conference:Digestive Disease Week	Leung, N Sherman, M Peng, CY Sollano, JD Lesmana, L Yuen, RMF Jeffers, L Hann, HW Menearini, K Colonno, R Cross, A Wilber, R Lopez-Talavera, JC	2007	100
Entecavir (ETV) therapy in chronic hepatitis B patients previously treated with adefovir (ADV) with incomplete response on-treatment or relapse off-treatment Proceeding/Conference:Journal of Hepatology	Lai, CL Elion, R Sherman, M Hann, HW Tyrell, DL Hsu, CW Tan, CK Peng, CY Leung, N Mercarni, K Zhang, H Iloeje, UH Kreter, B	2009	178
Entecavir (ETV) Therapy in Chronic Hepatitis B Patients Previously Treated with Adefovir (ADV) with Incomplete Response On-Treatment or Relapse Off-Treatment Proceeding/Conference:Gastroenterology	Lai, CL Elion, RA Sherman, M Hann, HW Tyrell, DL Hsu, CW Tan, CK Peng, CY Leung, N Mencarini, KA Zhang, H Iloeje, UH Kreter, B	2009	97
Entecavir (ETV) vs. Adefovir (ADV): HBV DNA reduction of viral load in chronically infected HBeAg(+) nucleoside naive adults in a 12-week Proceeding/Conference:Journal of clinical virology	Sherman, M Hann, HW Jeffers, L Min, A Leung, N Peng, CY Liaw, YF Sollano, J Lesmana, L Yuen, RMF Zhu, J Mencarini, K Colonno, R Cross, A Wilber, R Lopez-Talavera, JC	2006	151
Entecavir results in higher HBV DNA reduction vs adefovir in chronically infected HBeAg(+) antiviral-naive adults: 24 wk results (EARLY study) Proceeding/Conference:Hepatology	Leung, N Peng, CY Sollano, J Lesmana, L Yuen, RMF Jeffers, L Han, HW Sherman, M Zhu, J Menearini, K Colonno, RJ Cross, A Wilber, R Lopez-Talavera, JC	2006
Erratum: Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiretroviral therapy (Journal of Clinical Microbiology (2006) 44, 8 (2983-2987)) Journal:Journal of Clinical Microbiology	Hui, CK Bowden, S Zhang, HY Wong, A Lewin, S Rousseau, F MommejaMarin, H Lee, NP Luk, JM Locarnini, S Leung, N Naoumov, NV Lau, GKK	2007	38
Fibrosis progression in patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation Proceeding/Conference:Journal of Gastroenterology and Hepatology	Hui, CK Lau, E Kim, M Monto, A Luk, JMC Leung, N Lo, CM Fan, ST Wright, TL Lau, G	2006	140
Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy Journal:Gut	Hui, CK Cheung, WWW Au, WY Lie, AKW Zhang, HY Yueng, YH Wong, BCY Leung, N Kwong, YL Liang, R Lau, GKK	2005	127
Hepatitis B reactivation after withdrawal of preemptive lamivudine in patients with hematological malignancy upon completion of cytotoxic chemotherapy Journal:Liver International	Hui, CK Cheung, W Au, WY Lie, AKW Zhang, H Yueng, YH Wong, BCY Leung, N Kwong, YL Liang, RHS Lau, G	2005	172

Showing results 1 to 20 of 39 next >